Egg Diet to Improve Metabolic Health and Function
Does an Egg-Rich Diet Improve Metabolic Health and Function in Obese Older Adults
1 other identifier
interventional
34
1 country
1
Brief Summary
The purpose of this study is to determine the effects of change in diet quality (carbohydrate restriction versus fat restriction) on body composition, fat distribution, cardiometabolic risk factors, physical function, and quality of life in aging adults with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Jan 2015
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 28, 2016
CompletedFirst Posted
Study publicly available on registry
May 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedAugust 21, 2017
October 1, 2016
2.5 years
April 28, 2016
August 16, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Changes in total fat mass as measured by dual-energy X-ray absorptiometry (DXA)
8 weeks after baseline
Changes in visceral adipose tissue as measured by magnetic resonance imaging (MRI)
8 weeks after baseline
Changes in total lean mass as measured by DXA
8 weeks after baseline
Changes in subcutaneous abdominal adipose tissue as measured by MRI
8 weeks after baseline
Changes in thigh intermuscular adipose tissue as measured by MRI
8 weeks after baseline
Changes in thigh skeletal muscle volume as measured by MRI
8 weeks after baseline
Changes in thigh subcutaneous adipose tissue as measured by MRI
8 weeks after baseline
Secondary Outcomes (17)
Changes in pro-inflammatory markers, Interleukin (IL)-6
8 weeks after baseline
Changes in pro-inflammatory marker, hsCRP
8 weeks after baseline
Changes in pro-inflammatory marker, Tumor Necrosis Factor (TNF)-α
8 weeks after baseline
Changes in metabolic hormone adiponectin
8 weeks after baseline
Changes in metabolic hormone leptin
8 weeks after baseline
- +12 more secondary outcomes
Study Arms (2)
Egg-based diet (EBD)
EXPERIMENTALThis arm will provide ≤25% energy from CHO, 25% energy from protein, and ≥50% energy from fat. EBD participants will be asked to consume ≥2 eggs per day along with other protein sources including meat, fish, pork, and poultry. Carbohydrate (CHO) sources will be primarily derived from leafy greens and non-starchy vegetables and CHO intake will be equally distributed across meals throughout the day.
Carbohydrate-based diet (CBD)
PLACEBO COMPARATORThe CBD group will be asked to avoid whole egg consumption when possible during the 8 week intervention period. They will be counseled to consume a low fat diet with 55:25:20 %energy from CHO:protein:fat. This diet will place an emphasis on consuming lean meats, low fat dairy, whole grains, legumes, fruits and vegetables.
Interventions
Participants will be asked to consume a carbohydrate-restricted diet including whole eggs for 8 weeks. Eggs will be provided.
Participants will be asked to consume a low fat, carbohydrate-based diet for 8 weeks. Breakfast food items will be provided.
Eligibility Criteria
You may qualify if:
- between 60-75 years of age,
- have a BMI ranging from 30-40 kg/m2,
- sedentary (\<2h/wk of intentional exercise, and agree to maintain their level of activity throughout the study).
You may not qualify if:
- those with uncontrolled diabetes,
- unwilling to eat the prescribed diets,
- recent weight change (+/- 10 lbs. in previous year),
- history of eating disorder,
- difficulty chewing and swallowing solid food,
- digestive diseases,
- cognitive impairment,
- uncontrolled blood pressure (systolic blood pressure \> 159 or diastolic blood pressure \>95 mm Hg),
- history of non-skin cancer in the last 5 years,
- cardiovascular disease event; severe pulmonary disease; renal failure; major liver dysfunction,
- current/recent smoker,
- use of estrogen or testosterone replacement therapy,
- current use of oral corticosteroids (\>5 d/mth),
- using medications for treatment of psychosis or manic-depressive illness, and
- dependence on others for food procurement or preparation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- American Egg Boardcollaborator
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35223, United States
Related Publications (2)
Hoover SE, Il'yasova D, Fontaine KR, Spasojevic I, Gower BA, Goss AM. A Pilot Study of Associations Between Visceral Fat, IL-6, and Urinary F2-Isoprostanes in Older Adults Exposed to a Diet Intervention. Curr Dev Nutr. 2021 May 21;5(6):nzab082. doi: 10.1093/cdn/nzab082. eCollection 2021 Jun.
PMID: 34212125DERIVEDGoss AM, Gower B, Soleymani T, Stewart M, Pendergrass M, Lockhart M, Krantz O, Dowla S, Bush N, Garr Barry V, Fontaine KR. Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical trial. Nutr Metab (Lond). 2020 Aug 12;17:64. doi: 10.1186/s12986-020-00481-9. eCollection 2020.
PMID: 32817749DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin M Fontaine, PhD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigators
Study Record Dates
First Submitted
April 28, 2016
First Posted
May 3, 2016
Study Start
January 1, 2015
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
August 21, 2017
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share